Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
BROMAZEPAM Stage III Prostate Cancer AJCC v8	Fred Hutchinson Cancer Center	P1	CC (40)
T-Cell Receptor-Engineered T-Cells Prostate Small Cell Carcinoma	Fred Hutchinson Cancer Center	P1	CC (40)
T-Cell Receptor-Engineered T-Cells Prostate Cancer	Fred Hutchinson Cancer Center	P1	CC (40)
BROMAZEPAM Prostate Carcinoma	Fred Hutchinson Cancer Center	P1	C (39)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Chronic Myelomonocytic Leukemia	Fred Hutchinson Cancer Center	P1	C (39)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Minimal Residual Disease	Fred Hutchinson Cancer Center	P1	C (39)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Mixed Phenotype Acute Leukemia	Fred Hutchinson Cancer Center	P1	C (39)
Decoy-Resistant Interleukin-18 Myelodysplastic Syndrome	Fred Hutchinson Cancer Center	P1	C (39)
Imgn632 Myelodysplastic Syndrome	Fred Hutchinson Cancer Center	P1	C (39)
T-Cell Receptor-Engineered T-Cells Prostate Carcinoma	Fred Hutchinson Cancer Center	P1	C (39)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Leukemia	Fred Hutchinson Cancer Center	P1	C (37)
T-Cell Receptor-Engineered T-Cells Metastatic Malignant Neoplasm	Fred Hutchinson Cancer Center	P1	C (37)
Astatine At 211 Anti-Cd38 Monoclonal Antibody Okt10-B10 Plasma Cell Myeloma	Fred Hutchinson Cancer Center	P1	C (36)
Decoy-Resistant Interleukin-18 Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	C (36)
Rivogenlecleucel Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P1/2	C (34)
Autologous Hla-A*02:01-Restricted Cd4+/Cd8+ Anti-Wt1 Tcr/Cd8Ab-Expressing T-Cells Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	NR (0)
Autologous HLA-A*02:01-restricted CD4+ T-cells Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	NR (0)

Showing 551 to 567 of 567 assets

PreviousPage 23 of 23Next